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Background: Single nucleotide polymorphisms (SNPs) in lipoprotein lipase gene (LPL) have been shown to
influence metabolism related to lipid phenotypes. Dietary factors have been shown to modify the association
between LPL SNPs and lipids; however, to date, there are no studies in South Asians. Hence, we tested for the
association of four common LPL SNPs with plasma lipids and examined the interactions between the SNPs and
dietary factors on lipids in 1,845 Asian Indians.
Methods: The analysis was performed in 788 Type 2 diabetes cases and 1,057 controls randomly chosen from the
cross-sectional Chennai Urban Rural Epidemiological Study. Serum triacylglycerol (TAG), serum total cholesterol, and
high-density lipoprotein cholesterol (HDL-C) were measured using a Hitachi-912 autoanalyzer (Roche Diagnostics
GmbH, Mannheim, Germany). Dietary intake was assessed using a semi-quantitative food frequency questionnaire.
The SNPs (rs1121923, rs328, rs4922115 and rs285) were genotyped by polymerase chain reaction followed by
restriction enzyme digestion and 20% of samples were sequenced to validate the genotypes obtained. Statistical
Package for Social Sciences for Windows version 22.0 (SPSS, Chicago, IL) was used for statistical analysis.
Results: After correction for multiple testing and adjusting for potential confounders, SNPs rs328 and rs285 showed
association with HDL-C (P = 0.0004) and serum TAG (P = 1×10−5), respectively. The interaction between SNP
rs1121923 and fat intake (energy %) on HDL-C (P = 0.003) was also significant, where, among those who consumed
a high fat diet (28.4 ± 2.5%), the T allele carriers (TT + XT) had significantly higher HDL-C concentrations (P = 0.0002)
and 30% reduced risk of low HDL-C levels compared to the CC homozygotes. None of the interactions on other
lipid traits were statistically significant.
Conclusion: Our findings suggest that individuals carrying T allele of the SNP rs1121923 have increased HDL-C
levels when consuming a high fat diet compared to CC homozygotes. Our finding warrants confirmation in
prospective studies and randomized controlled trials.
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The Asian Indian population has a greater predisposition
to non-communicable diseases such as type 2 diabetes
(T2D) [1, 2] and cardiovascular disease (CVD) [3] com-
pared to Europeans. Despite low body mass index (BMI),
Indians are characterized by a higher frequency of hyper-
insulinemia [4], insulin resistance [5], dyslipidemia with
hypertriacylglycerolemia and low high-density lipoprotein
cholesterol (HDL-C) levels [6] and increased visceral fat,
which are referred to as ‘Asian Indian Phenotype’ or
‘Atherogenic Lipoprotein Phenotype’ [7, 8]. Blood lipid
levels are heritable phenotypes and findings from previous
studies show that the blood concentrations of HDL-C,
low density lipoprotein cholesterol (LDL-C) and triacyl-
glycerol (TAG) have a strong inheritance [9].
Genetic studies have implicated several gene loci in the
predisposition to dyslipidemia in Asian Indians [10–13],
one of which is lipoprotein lipase (LPL) [14–16]. LPL plays
an important role in the metabolism of HDL-C, where it
has been shown to hydrolyze TAG in TAG-rich lipopro-
teins such as chylomicrons and very low density lipopro-
teins [17]. It has been postulated that increased activity of
LPL enzyme enhances the release of components of TAG-
rich lipoproteins which are then transferred to HDL to raise
HDL levels; conversely, lack of LPL can retard the transfer
of these components to HDL [18]. Several candidate gene
studies have shown an association between single nucleo-
tide polymorphisms (SNPs) in LPL and lipid traits in vari-
ous populations including Asian Indians [11, 12, 19–22].
Genome wide association studies have also demonstrated
strong evidence for the association of LPL polymorphisms
with HDL-C concentrations [23–25]. A few studies have
examined the LPL gene–diet interactions in association
with HDL-C [26–30]; however, the findings have been quite
inconsistent due to variations in sample size, dietary factors
and the selection of LPL polymorphisms.
Given that there are no gene-diet interaction studies,
to date, in Asian Indian populations, we examined the
association of four common LPL SNPs [Val135Val C/T
(rs1121923), Ser447Ter C/G (rs328), G/A (rs4922115)
and Pvu II C/T (rs285)] with HDL-C and investigated
the interactions of these four polymorphisms with
dietary carbohydrate, fat and protein percentage on
HDL-C in up to 1,845 participants (788 T2D cases and
1,057 controls) from the cross-sectional Chennai Urban
Rural Epidemiological Study (CURES). In addition, we
examined the genetic associations and interactions for
other lipid traits such as TAG, LDL-C and total choles-
terol in these participants.
Methods
Study population
One thousand eight hundred and forty five participants
comprising 788 cases with T2D and 1,057 controls withnormal glucose tolerance (NGT) were randomly chosen
from the urban component of the Chennai Urban Rural
Epidemiological Study (CURES), an epidemiological study
conducted on a representative population (age >20 years)
of Chennai (formerly Madras), the fourth largest city in
India. The detailed methodology of the study participants is
published elsewhere [31]. Briefly, in Phase 1 of CURES,
26,001 individuals were recruited based on a systematic
random sampling technique. Participants with self-reported
diabetes taking drug treatment for diabetes were classified
as “known diabetes subjects.” All known diabetes partici-
pants (n = 1,529) were invited to visit the center for detailed
studies. In addition, every 10th individual of the 26,001 in-
dividuals without known diabetes was invited to undergo
oral glucose tolerance tests using a 75-g oral glucose load
(dissolved in 250 ml of water) (Phase 3 of CURES). Those
who were confirmed by oral glucose tolerance test to have
2-h plasma glucose value ≥11.1 mmol/l based on World
Health Organization (WHO) consulting group criteria were
labeled as “newly detected diabetes subjects” and those with
2-h plasma glucose value <7.8 mmol/l as being NGT [32].
CURES participants who were on lipid lowering drugs
such as statins, fibrates and niacin were excluded
from the study (n = 134). On the basis of the National
Cholesterol Education Program-Adult Treatment Panel
III (NCEP-ATP III) guidelines [33] the study population
was divided into those with normal HDL-C (≥1.03 mmol/l
for men; ≥1.3 mmol/l for women) and low HDL-C
(<1.03 mmol/l for men; <1.3 mmol/l for women).
Written informed consent was obtained from each
study participant, and the study was approved by the
Madras Diabetes Research Foundation Institutional
Ethics Committee.
Phenotype measurements
Anthropometric measurements including weight, height,
and waist were obtained using standardized techniques.
The BMI was calculated as weight (in kg) divided by the
square of height (in m). Biochemical analyses were per-
formed on a Hitachi-912 Auto Analyzer (Hitachi, Mannheim,
Germany) using kits supplied by Roche Diagnostics
(Mannheim). Fasting plasma glucose (glucose oxidase–
peroxidase method), serum total cholesterol (cholesterol
oxidase-phenol-4-amino-antipyrene peroxidase method),
serum TAG (glycerol phosphatase oxidase-phenol-4-
amino-antipyrene peroxidase method), and HDL-C (direct
method; polyethylene glycol-pretreated enzymes) were mea-
sured. Low-density lipoprotein cholesterol was calculated
using the Friedewald formula [34]. Glycated haemoglobin
(HbA1c) was estimated by high-performance liquid
chromatography using a Variant™ machine (Bio-Rad,
Hercules, CA, USA). Serum insulin concentration was
estimated using an enzyme-linked immunosorbent assay
(Dako, Glostrup, Denmark).
Table 1 Baseline characteristics of the CURES study participants
Participants with normal
glucose tolerance
(N = 1,057)
Participants with
type 2 diabetes
(N = 788)
P value
Age (year) 38.5 ± 13.6 50.6 ± 11.1 <0.0001
Gender
(men/women)
608/ 449 433/355 0.2*
BMI (kg/m2) 23.2 ± 4.5 25.2 ± 4.4 <0.0001
Fasting Glucose
(mmol/l)
4.7 ± 0.5 8.8 ± 3.8 <0.0001
Fasting Insulin
(lIU/mL)
8.2 ± 5.6 11.6 ± 7.0 <0.0001
Total serum
Cholesterol
(mmol/l)
4.6 ± 0.9 5.2 ± 1.1 <0.0001
Serum TAG
(mmol/l)
1.3 ± 0.7 1.9 ± 1.3 <0.0001
HDL-C (mmol/l) 1.12 ± 0.25 1.08 ± 0.24 0.003
LDL-C (mmol/l) 2.9 ± 0.8 3.2 ± 0.9 <0.0001
Glycated
hemoglobin (%)
5.56 ± 0.47 8.64 ± 2.26 <0.0001
Systolic pressure
(mmHg)
117.0 ± 17.4 128.9 ± 21.5 <0.0001
Diastolic pressure
(mmHg)
73.2 ± 11.2 77.1 ± 12.0 <0.0001
Protein intake
(energy %)
11.3 ± 1.2 11.4 ± 1.2 0.03
Carbohydrate
intake (energy %)
64.4 ± 6.4 64.9 ± 5.8 0.1
Fat intake
(energy %)
23.5 ± 4.7 23.4 ± 4.6 0.8
Total energy
intake (kcal)
2627.2 ± 725.4 2533.5 ± 907.2 0.02
Total saturated
fat intake (%)
2.4 ± 0.9 2.1 ± 0.9 <0.0001
Total
monounsaturated
fat (%)
1.9 ± 0.7 1.7 ± 0.8 0.0002
Total
polyunsaturated
fat (%)
1.6 ± 0.8 1.7 ± 0.9 0.04
Data shown are represented as means ± SD, wherever appropriate
P values for the differences in the means/ proportions between cases
and controls
P values were calculated by using Independent t test
*P value was calculated using a Chi-square test
CURES Chennai Urban Rural Epidemiological Study, TAG triacylglycerol,
HDL-C high density lipoprotein, LDL-C low density lipoprotein cholesterol
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Dietary intakes were assessed using a previously validated
and published [35] interviewer administered semi-
quantitative food frequency questionnaire (FFQ) contain-
ing 222 food items to estimate food intake over the past
year. Briefly, individuals were asked to estimate the usual
frequency (number of times per day, week, month or
year/never) and the usual serving size of the portion of the
various food items in the FFQ. Common household
measures such as household cups, bowls, ladles, spoons
(for the cooked foods like vegetables), wedges, circles of
different diameter and visual atlas of different sizes of
fruits (small, medium, large) were shown to assist the
individuals in estimating portions. A detailed description
of the development of FFQ and the data on reproducibility
and validity had been published [35]. EpiNu, an in-house
database was used to assess the average daily food and
nutrient intake.
SNP selection and genotyping
Four common SNPs in the LPL gene (rs285, rs328,
rs4922115 and rs1121923) were chosen for the present
study. The SNPs rs328 and rs285 were chosen based on
their previous associations with lipid outcomes in several
populations [11, 12, 22, 36]. The SNPs rs1121923 and
rs4922115 were identified from the dbSNP database
(http://www.ncbi.nlm.nih.gov/SNP/) based on their
location in the exon 3 and 3’UTR regions, respectively,
assuming that variations in the coding and regulatory
regions might confer a functional effect on the gene
expression. The SNPs were genotyped by polymerase
chain reaction on a GeneAmp® PCR system 9700
thermal cycler (Applied Biosystems, Foster City, CA)
followed by restriction enzyme digestion (New England
Biolabs, Inc., Beverly, MA). The program usually had the
following steps: initial denaturation at 95 °C for 10 min,
30–35 cycles of denaturation at 95 °C for 45 s, primer-
annealing at 58 °C for rs1121923 and rs285 SNPs and
60 °C for rs328 and rs4922115 SNPs for 45 s, and primer
extension at 72 °C for 45 s, followed by a final extension
at 72 °C for 5 min. The restrictions enzymes used for
genotyping the SNPs were Sau96I for rs1121923, Mnl I
enzyme for rs328, the Eco RV enzyme for rs4922115 and
Pvu II for rs285. Agarose gel electrophoresis was used to
detect the amplification of PCR reaction and the restric-
tion enzyme digested products. To ensure that the geno-
typing was of adequate quality, we performed random
duplicates in 10% of the samples. The assays were per-
formed by a technician who was masked to the pheno-
type, and there was 98% concordance in the genotyping.
Variants were also confirmed by direct sequencing using
an ABI 3500 genetic analyzer (Applied Biosystems,
Foster City, CA). Population stratification was performed
using a case–control approach at 6 unlinked marker locibelieved to be unrelated to the disease under study, but
known to have allelic diversity among different popula-
tions [37].
Statistical analysis
Statistical Package for Social Sciences for Windows
version 22.0 (SPSS, Chicago, IL) was used for statistical
analysis. The effects of the variants on quantitative and
Table 2 Association of the lipoprotein lipase single nucleotide
polymorphisms (SNPs) with HDL-C levels
Association of the SNPs with HDL-C levels (continuous variable)
SNP HDL-C levels (means ± SD)
SNP rs4922115
GG 1.1 ± 0.3
GA 1.1 ± 0.2
AA 1.1 ± 0.2
Dominant model (GG vs
GA + AA) (P value)
0.02
SNP rs1121923
CC 1.1 ± 0.3
CT 1.2 ± 0.3
TT 1.0 ± 0.2
Dominant model (CC vs
CT + TT) (P value)
0.02
SNP rs328
CC 1.1 ± 0.3
CG 1.2 ± 0.3
GG 1.2 ± 0.2
Dominant model (CC vs
CG + GG) (P value)
0.0004
SNP rs285
CC 1.1 ± 0.3
CT 1.1 ± 0.2
TT 1.2 ± 0.2
Dominant model (CC vs
CT + TT) (P value)
0.03
Association of the SNPs with HDL-C (categorical variable)
Low HDL-C levels
Number (%)
Normal HDL-C levels
Number (%)
SNP rs4922115
GG 366 (65%) 497 (71.3%)
GA 171 (30.4%) 167 (25.3%)
AA 26 (4.6%) 24 (3.4%)
Dominant model (GG vs
GA + AA) (P value)
0.02
SNP rs1121923
CC 530 (91.7%) 642 (84.7%)
CT 45 (7.8%) 112 (14.8%)
TT 3 (0.5%) 4 (0.5%)
Dominant model (CC vs
CT + TT) (P value)
0.1
SNP rs328
CC 336 (78.3%) 540 (69.8%)
CG 88 (20.5%) 215 (27.8%)
GG 5 (1.2%) 19 (2.5%)
Dominant model (CC vs
CG + GG) (P value)
0.001
Table 2 Association of the lipoprotein lipase single nucleotide
polymorphisms (SNPs) with HDL-C levels (Continued)
SNP rs285
CC 336 (45.6%) 421 (38%)
CT 330 (44.8%) 515 (46.5%)
TT 71 (9.6%) 171 (15.4%)
Dominant model (CC vs
CT + TT) (P value)
0.001
HDL-C High density lipoprotein cholesterol
P values are adjusted for age, gender, body mass index, and Type 2
diabetes status
Those p values that are in bold implicates those values that are significant
after Bonferroni correction
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were estimated by gene counting. Agreement with
Hardy–Weinberg equilibrium (HWE) expectations was
tested using a χ2goodness-of-fit test. Comparison of the
means between the two groups was analyzed by inde-
pendent t-test. The χ2 test was used to compare the pro-
portions of genotypes or alleles. Dominant model was
used, given the low frequency of minor allele homozy-
gotes. Linear regression was used to examine the association
of the LPL SNPs with various lipid outcomes. The SNP-diet
interactions on lipid traits were tested by including the
interaction term in linear regression models. Models were ad-
justed for age, gender, BMI (as continuous), T2D status and
total energy intake wherever appropriate. Multiple testing
correction using Bonferroni method was applied separately
for the testing of main and interaction effects (i.e., association
of the four SNPs with HDL-C and interaction with dietary
factors on HDL-C levels) [P ≤ 0.003 (=0.05/20) was consid-
ered statistically significant] and additional analyses (i.e.,
association of the four SNPs with other lipid traits and
interaction with dietary factors on other lipid traits) [P ≤
0.001 (=0.05/48) was considered statistically significant].
Results
Table 1 shows the anthropometric and biochemical char-
acteristics of NGT and T2D participants. T2D cases had
markedly increased levels of TAG, LDL-C and total chol-
esterol, while HDL-C was significantly lower in cases
compared to controls (P < 0.003 for all comparisons). In
our study population, the genotype distributions for the
four LPL polymorphisms were GG: 68.5%, GA: 27.5% and
AA: 4.0% (rs4922115); CC: 87.5%, CT: 12.0% and TT: 0.5%
(rs1121923); CC: 72.8%, CG: 25.2% and GG: 2.00%
(rs328); and CC: 40.9%, CT: 45.6% and TT: 13.5% (rs285).
All the four SNPs were in HWE (P > 0.05).
The association between LPL SNPs and HDL-C levels
is presented in Table 2. Of the four LPL variants, the
SNP rs328 alone showed a significant and a consistent
association with HDL-C concentrations [both as con-
tinuous and categorical variable (stratified based on
NCEP ATP III guidelines)] under a dominant model
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continuous variable and P = 0.001 for the categorical
variable). The minor allele (G) carriers of the SNP rs328
had 5% higher HDL-C compared to the homozygous
carriers of the common ‘C’ allele.
In the interaction analysis, after correction for multiple
testing, none of the interactions were statistically signifi-
cant except for the interaction between SNP rs1121923
and fat intake (energy %) on HDL-C (P = 0.003) (Table 3),
where among those who consumed a high fat diet (3rd
tertile: 28.4 ± 2.5%), the T allele carriers had significantly
higher HDL-C concentrations compared to the CC
homozygotes (P = 0.0002) (Fig. 1a). To test whether this
interaction was significant on HDL-C as a categorical
variable, we stratified the data based on normal and low
HDL-C levels according to the NCEP ATP III guidelines
for dyslipidemia [33] and found that among those who
consumed a high fat diet, the individuals who carried
the T allele had 30% reduced risk of low HDL-C levels
compared to the CC homozygotes (P = 0.001) (Fig. 1b).
We further investigated the interaction of the SNP with
various fat subclass intakes on HDL-C but none of the
interactions were statistically significant [monounsatu-
rated (MUFA) (P = 0.36), polyunsaturated (PUFA) (P =
0.22) and saturated fatty acids (SFA) (P = 0.46)].
The SNP rs285 alone showed a significant association
with serum TAG (P = 1 × 10−5), where CC genotype
carriers had higher TAG concentrations than T allele
carriers (Table 4). In the interaction analysis, there was
an interaction of the LPL SNP rs4922115 with fat intake
(energy %) on TAG, where, among those who consumed
a low (1st tertile: 18.1 ± 2.6%) or medium fat (2nd tertile:
23.4 ± 1.1%) diet, individuals carrying the GG genotype
had significantly lower TAG concentrations compared to
‘A’ allele carriers (P = 0.01 for low fat intake; P = 0.02 forTable 3 Interaction between lipoprotein lipase single nucleotide po
Beta coefficients ± standard error (Pinteraction) for interaction on HDL-C (contin
Interaction between rs4922115* fat
energy intake (%)
Interaction between rs4922
energy intake (%)
−0.01 ± 0.002 (0.1) −0.02 ± 0.01 (0.2)
Interaction between rs1121923* fat
energy intake (%)
Interaction between rs1121
energy intake (%)
−0.01 ± 0.01 (0.003) −0.3 ± 0.01 (0.02)
Interaction between rs328* fat
energy intake (%)
Interaction between rs328*
energy intake (%)
−0.01 ± 0.002 (0.16) −0.02 ± 0.01 (0.12)
Interaction between rs285* fat
energy intake (%)
Interaction between rs285*
energy intake (%)
0.01 ± 0.002 (0.05) 0.02 ± 0.01 (0.04)
HDL-C High density lipoprotein cholesterol
Pinteraction values adjusted for age, gender, body mass index, type 2 diabetes and to
(*) refers to the interaction between SNP and dietary factor
Those p values that are in bold implicates those values that are significant after Bonmedium fat intake). However, after correction for
multiple testing, this interaction was not statistically sig-
nificant. None of the other interactions between the
SNPs and dietary factors on total cholesterol, serum
TAG and LDL-C were statistically significant (Additional
file 1: Table S1).
Discussion
To our knowledge, this is the first genetic epidemio-
logical study to investigate the interaction between SNPs
at LPL gene and dietary factors on blood lipids in an
Asian Indian population. Our study provides evidence
for a novel interaction between SNP rs1121923 and fat
intake (energy %) on HDL-C, where the T allele carriers
had significantly higher levels of HDL-C compared to
the CC homozygotes among those who consumed a high
fat diet. Given that the total fat intake has increased in
India in the last few decades and Asian Indians are
characterized by altered lipid levels and at a higher risk
of premature coronary artery disease (CAD) [38], our
study findings have significant public health implications.
Several LPL polymorphisms have been extensively stud-
ied in association with various lipid traits [12, 22, 25, 26].
The most notable of these known functional common
polymorphisms is rs328, also known as S447X (premature
truncation at codon 447). SNP rs328 is a gain-of-function
polymorphism that has been shown to be consistently
associated with higher HDL-C [12]. Our study has also
shown a significant association of the SNP rs328 with
HDL-C concentrations, where the minor ‘G’ allele carriers
had significantly higher HDL-C compared to those with
common CC genotype. The rs285 (Pvu II) variant located
in the intron 6 of the LPL gene has been shown to be
associated with dyslipidemic phenotypes such as low
HDL-C and high TAG among Caucasians [39], which is inlymorphisms and dietary factors on HDL-C levels
uous variable)
115* protein Interaction between rs4922115* carbohydrate
energy intake (%)
0.01 ± 0.02 (0.06)
923* protein Interaction between rs1121923* carbohydrate
energy intake (%)
0.01 ± 0.002 (0.05)
protein Interaction between rs328* carbohydrate
energy intake (%)
0.01 ± 0.002 (0.07)
protein Interaction between rs285* carbohydrate
energy intake (%)
−0.01 ± 0.002 (0.03)
tal energy intake
ferroni correction
Fig. 1 a Interaction between Lipoprotein lipase gene SNP rs1121923 and fat energy intake (%) on HDL-C concentrations (Pinteraction = 0.003). Among those
who consumed a high fat diet, T allele carriers had significantly higher levels of HDL-C compared to the CC homozygotes (P=0.0002). b Interaction between
Lipoprotein lipase gene SNP rs1121923 and fat energy intake (%) on HDL-C as a categorical variable (Pinteraction = 0.01). Among those who consumed a high
fat diet (28.4%), the individuals who carried the T allele have 30% reduced risk of low HDL-C levels compared to those who carry the CC genotype (P=0.001).
Data shown are represented as means ± SE. Pinteraction values adjusted for age, gender, body mass index, type 2 diabetes and total energy intake
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where the CC genotype carriers of the SNP rs285 had sig-
nificantly higher TAG than T allele carriers. The ‘A’ allele
of the SNP rs4922115 (located in the 3′ UTR region) and
‘C’ allele of the SNP rs1121923 (Val135Val) (located in the
exon 3) were also associated with lower HDL-C levels in our
study; however, after correction for multiple testing they were
not significant. Our findings confirm the previously reported
associations and reveal that LPL SNPs play an important role
in lipid metabolism in this Asian Indian population.
Total fat intake has increased considerably in India in
the last few decades [40]. The National Sample Survey
Organization survey has reported that the fat intake of
urban component of Indian populations has increased
from 42.0 g/d/capita in 1993–1994 to 52.5 g/d/capita in
2011–2012 [41]. Interestingly our study in this SouthIndian population has identified an interaction between
LPL SNP rs1121923 and fat intake (energy %) on HDL-C,
where, among those who consumed a high fat diet
(28.4%), individuals carrying the T allele had significantly
higher HDL-C concentrations compared to the CC geno-
type carriers. Even though our study is the first to report
this gene-diet interaction, previous studies in developing
countries have shown that the quantity of dietary fats can
affect the lipid profile and is directly related to the devel-
opment of metabolic diseases such as obesity and diabetes
[42, 43]. Quality of dietary fat has also shown to alter
blood lipid levels [43] but the present study failed to iden-
tify an interaction of the LPL SNP with MUFA, PUFA and
SFA, respectively, on lipid traits. Vegetable oils used in
Indian cooking represent 80% of the visible fat consumed
[44] and a study in an Indian population showed that the
Table 4 Association between single nucleotide polymorphisms
(SNPs) at lipoprotein lipase gene and lipid traits
SNPs Total cholesterol
mmol/l
Triglycerides
mmol/l
LDL-C
mmol/l
SNP rs4922115
GG 4.9 ± 1.1 1.6 ± 1.0 3.1 ± 0.9
GA 4.8 ± 1.1 1.9 ± 1.8 3.0 ± 0.9
AA 4.7 ± 0.9 1.7 ± 0.8 2.9 ± 0.8
Dominant model (GG vs
GA + AA) (P value)
0.4 0.001 0.1
SNP rs1121923
CC 4.8 ± 1.1 1.7 ± 1.4 3.0 ± 0.9
CT 5.1 ± 1.0 1.7 ± 1.0 3.2 ± 0.9
TT 4.9 ± 0.6 1.4 ± 0.4 3.3 ± 0.4
Dominant model (CC vs
CT + TT) (P value)
0.4 0.3 0.9
SNP rs328
CC 4.9 ± 1.0 1.7 ± 1.1 3.1 ± 0.9
CG 4.9 ± 1.1 1.5 ± 0.9 3.1 ± 0.9
GG 5.0 ± 0.9 1.4 ± 0.5 3.2 ± 0.8
Dominant model (CC vs
CG + GG) (P value)
0.3 0.1 0.3
SNP rs285
CC 4.8 ± 1.1 1.7 ± 1.2 3.0 ± 0.8
CT 4.8 ± 1.1 1.5 ± 0.9 3.1 ± 0.9
TT 4.8 ± 1.0 1.4 ± 0.8 3.0 ± 0.8
Dominant model (CC vs
CT + TT) (P value)
0.7 0.00009 0.4
LDL-c Low density lipoprotein cholesterol
Results are expressed as mean ± SD
P values adjusted for age, gender, body mass index and type 2 diabetes
Those p values that are in bold implicates those values that are significant
after Bonferroni correction
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tity of oil used [45]. Previous studies have shown that diet-
ary fat increases HDL-C [46], which is partially explained
by our study findings where the T allele carriers of the
SNP rs1121923, who consumed a high fat diet, had higher
HDL-C concentrations compared to CC genotype carriers.
Even though the exact mechanism by which T allele con-
tributes to the increase in HDL-C levels under conditions
of high fat diet is unknown, the finding is suggestive of the
complex inheritance pattern of the HDL-C levels [47],
where several genes/polymorphisms are likely to contrib-
ute to the alteration of HDL-C levels through gene-gene
and gene-diet interactions. Our findings are supported by
animal studies [48] where mice that are challenged with a
high fat diet showed a strong correlation between LPL
activity and HDL cholesterol suggesting the link between
LPL, fat intake and HDL levels.
Besides HDL-C, there were interactions of the LPL
SNP rs4922115 with fat energy intake (%) on TAG,where, among those who consumed a low or medium
fat diet, individuals carrying the GG genotype had sig-
nificantly lower TAG concentrations compared to ‘A’ al-
lele carriers. The SNP rs4922115 has not been studied
previously in other populations except in Hispanics [49],
where this SNP was identified by direct sequencing.
However, the study did not explore the individual effect
of the SNP on blood lipids and hence we are unable to
compare our findings with the Hispanic study. Even
though the interaction between SNP rs4922115 and fat
energy intake (%) was not statistically significant after
Bonferroni correction in our study, replication of these
interactions in another large cohort is highly warranted.
One of the main limitations of the study is the small
sample size. Given that there are no previously reported
effect sizes for the LPL SNP-diet interaction on blood
lipids, we are unable to calculate the statistical power for
our study. However, we were still able to identify signifi-
cant gene-diet interactions on HDL-C even after correc-
tion for multiple testing. The interaction was significant
only with total fat intake (energy %) but not when split
as PUFA, MUFA and SFA, which might be due to small
sample size. Nevertheless, our study is well powered to
identify the effect sizes for association between the SNPs
and lipids. To increase the statistical power, individuals
with and without T2D were included and hence it is
possible that the T2D status could have introduced a
bias in our study as the dietary pattern is likely to be
changed among ‘known’ diabetic participants. However,
T2D status was adjusted in all the analyses and the inter-
action findings were borderline significant even after
excluding the ‘known’ diabetic participants from our
analysis (data not shown), which could also be due to
the small sample size after exclusion. Another limitation
is that, our study was cross-sectional and therefore was
unable to examine the casual relationship between fat
intake and lowering of HDL-C levels; randomized
controlled trials with prospective genotyping are re-
quired to explore the causality using genetic markers.
The main strength of the present study is that a vali-
dated interviewer-administered FFQ was used to meas-
ure the usual long-term intake of the population.
Furthermore, the sampling is representative of the over-
all population of Chennai. Indeed, the intake of major
foods in our study was similar to the findings of the
pooled urban data of the National Nutrition Monitoring
Bureau for ten states in India [50] and hence, the results
of the present study could be reasonably extrapolated to
urban Indian population.
Conclusions
Our study confirms the association between LPL SNP
rs328 and HDL-C concentrations and also provides an
evidence for a novel interaction between SNP rs1121923
Ayyappa et al. Nutrition & Metabolism  (2017) 14:8 Page 8 of 9and fat intake (energy %) on HDL-C levels in this Asian
Indian population. Given that Asian Indians have altered
lipid profile and an increased predisposition to prema-
ture CAD [38, 40], our study suggesting that individuals
carrying T allele of the SNP rs1121923 have increased
HDL-C levels when consuming a high fat diet has
significant public health implications. This finding war-
rants confirmation in prospective studies and randomized
controlled trials.
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